Form 4: Nuvalent Executive Sells Shares to Cover Tax Obligations After RSU Vesting
SEC Form 4 Filing
Darlene Noci, Chief Development Officer of Nuvalent, Inc., sold shares of Class A Common Stock to cover tax obligations following the vesting of restricted stock units.
Summary
- Darlene Noci, Chief Development Officer of Nuvalent, Inc., reported transactions involving the company's Class A Common Stock on January 6, 2025.
- Noci acquired 18,750 shares through the vesting of restricted stock units (RSUs) at a price of $0.00 per share.
- Simultaneously, Noci sold a total of 4,016 shares in multiple transactions to cover tax withholding obligations related to the vesting RSUs.
- The sales were executed under a pre-arranged Rule 10b5-1 sell-to-cover plan established on December 6, 2023.
- The sale prices ranged from $78.02 to $81.03 per share.
- Following these transactions, Noci directly owns 50,207 shares of Nuvalent, Inc. Class A Common Stock.
- Noci was also granted an option to buy 37,500 shares of Class A Common Stock at an exercise price of $78.09, vesting monthly over four years from January 6, 2025, and expiring on January 6, 2035.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and tax obligations. The use of a 10b5-1 plan is a positive sign of transparency.
Positives
- The vesting of RSUs indicates that the executive is meeting the conditions of their equity compensation plan.
- The use of a pre-arranged 10b5-1 trading plan suggests transparency and avoids concerns about insider trading.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. The use of 10b5-1 plans is a common practice to allow insiders to sell shares without raising concerns about trading on non-public information.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and restricted stock units (RSUs).
- Vesting schedules for RSUs and stock options are typically tied to continued employment with the company.
- Rule 10b5-1 trading plans are a standard tool for corporate insiders to manage their stock sales in compliance with securities laws.
- The size of the RSU grant and stock option grant is typical for a Chief Development Officer at a company of Nuvalent's size and stage.
Stakeholder Impact
- The transactions have a minimal impact on shareholders, as the sales are part of a pre-arranged plan and do not indicate a change in the executive's long-term outlook for the company.
- Employees may view the vesting of RSUs and stock options as a positive sign of the company's commitment to employee compensation.
Key Dates
| Date | Description |
|---|---|
| 2023-12-06 | Date of durable Rule 10b5-1 sell-to-cover instruction letter. |
| 2025-01-06 | Date of transaction: RSU vesting, stock sales, and stock option grant. |
| 2025-01-06 | RSUs vest in three equal annual installments following this date. |
| 2025-01-06 | Stock options vest over the four years following this date in equal monthly installments. |
| 2035-01-06 | Expiration date of the stock options. |
| 2025-01-08 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.